Found 1137 matching trials
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
PHASE3The purpose of this study is to assess if adding revumenib to standard chem...
Location
Clinical Trial Site
Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial
NAWith this trial, the aim is to assess the benefits and harms of a non-surgi...
Location
Steno Diabetes Center Aarhus, Aarhus Universitets Hospital
Study to Assess an Interphase Cycle With Flotetuzumab.
PHASE2Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Location
NL-Amsterdam-VUMC
Adaptation and Implementation of an Intensive Geriatric Service Worker (IGSW) Model of Care for Socially Isolated Older Adults
NAIn this study, participants will be randomly assigned to receive either the...
Location
Multiple Locations
Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation
NA1. OBJECTIVES:
General objective: Assess the effects of a music therapy...
Location
Araba university hospital
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
PHASE2The goal of this clinical trial is to learn if participants treated with th...
Status
Active Not Recruiting
Location
Banner MD Anderson
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma
PHASE2A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Location
University Hospital
A Study of FMT in Patients With AML Allo HSCT in Recipients
PHASE2This is a randomized, double-blind, placebo-controlled clinical trial of Fe...
Location
Masonic Cancer Center at University of Minnesota
Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures
NABACKGROUND Recent evidence has been published about the effectiveness for t...
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
PHASE3The purpose of this study is to compare a standard chemotherapy regimen of ...
Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimenInduction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimenInduction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimenInduction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimenInduction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimenConsolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimenMaintenance (intensive & non-intensive pathways) - lenalidomide maintenanceMaintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenanceHigh dose melphalan therapy and autologous stem cell transplant (intensive pathway only)